Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mineo Takei

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Biological & Pharmaceutical Bulletin|February 2, 2010
Pharmacological evaluation of analgesic effects of the cholecystokinin2 receptor antagonist Z-360 in mouse models of formalin- and cancer-induced painKoji Yoshinaga, Takayuki Horii, Hiroki Hamano, et al.
Molecular Pharmaceutics|May 11, 2011
Concentration dependence of 5-aminosalicylic acid pharmacological actions in intestinal mucosa after oral administration of a pH-dependent formulationMasamichi Hirayama, Ryoko Toda, Tomoko Ozaki, et al.
European Journal of Pharmacology|June 10, 2011
Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in ratsMasanao Kawachi, Yugo Matsunaga, Takao Tanaka, et al.
BJU International|November 11, 2010
Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunctionMasayuki Takeda, Yukio Homma, Isao Araki, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2010
Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosaprideYugo Matsunaga, Takao Tanaka, Koji Yoshinaga, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 2, 2021
Clinical Guidelines for Female Lower Urinary Tract Symptoms (second edition)Satoru Takahashi, Mineo Takei, Hirotaka Asakura, et al.
Lower Urinary Tract Symptoms|January 21, 2016
Clinical Guideline for Female Lower Urinary Tract SymptomsSatoru Takahashi, Mineo Takei, Osamu Nishizawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 14, 2022
The Asia-Pacific AMS800 artificial urinary sphincter consensus statementEric Chung, Limin Liao, Jang Hwan Kim, et al.
Neurourology and Urodynamics|August 1, 2007
Defining overactive bladder as hypersensitivityOsamu Yamaguchi, Kazuya Honda, Masanori Nomiya, et al.
Neurourology and Urodynamics|February 26, 2019
The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladderAlan D Uren, Nikki Cotterill, Christopher Harding, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Biological & Pharmaceutical Bulletin|February 2, 2010
Pharmacological evaluation of analgesic effects of the cholecystokinin2 receptor antagonist Z-360 in mouse models of formalin- and cancer-induced painKoji Yoshinaga, Takayuki Horii, Hiroki Hamano, et al.
Molecular Pharmaceutics|May 11, 2011
Concentration dependence of 5-aminosalicylic acid pharmacological actions in intestinal mucosa after oral administration of a pH-dependent formulationMasamichi Hirayama, Ryoko Toda, Tomoko Ozaki, et al.
European Journal of Pharmacology|June 10, 2011
Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in ratsMasanao Kawachi, Yugo Matsunaga, Takao Tanaka, et al.
BJU International|November 11, 2010
Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunctionMasayuki Takeda, Yukio Homma, Isao Araki, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2010
Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosaprideYugo Matsunaga, Takao Tanaka, Koji Yoshinaga, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 2, 2021
Clinical Guidelines for Female Lower Urinary Tract Symptoms (second edition)Satoru Takahashi, Mineo Takei, Hirotaka Asakura, et al.
Lower Urinary Tract Symptoms|January 21, 2016
Clinical Guideline for Female Lower Urinary Tract SymptomsSatoru Takahashi, Mineo Takei, Osamu Nishizawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 14, 2022
The Asia-Pacific AMS800 artificial urinary sphincter consensus statementEric Chung, Limin Liao, Jang Hwan Kim, et al.
Neurourology and Urodynamics|August 1, 2007
Defining overactive bladder as hypersensitivityOsamu Yamaguchi, Kazuya Honda, Masanori Nomiya, et al.
Neurourology and Urodynamics|February 26, 2019
The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladderAlan D Uren, Nikki Cotterill, Christopher Harding, et al.
Pageof 7